Pacific Region Vaccine Access
There is no higher priority for countries in our region than access to safe and effective COVID-19 vaccines.
Australia has committed $623.2 million over three years to the Regional Vaccine Access and Health Security Initiative. This includes $100 million for a landmark vaccine partnership with Quad partners (the United States of America, India and Japan) which aims to provide over one billion vaccines to the Indo-Pacific by 2022. In addition, Australia has also contributed $215 million to the global COVAX Facility Advance Market Commitment, and we are working on arrangements to provide doses from Australia’s own supply pipeline across the region, subject to domestic requirements.
The Regional Vaccine Access and Health Security initiative will direct $200 million to the Pacific to support their vaccine access and rollout needs. Our approach is holistic, with funding to procure and deliver COVID-19 vaccines and support related technical assistance in Fiji, Kiribati, Nauru, Papua New Guinea, Samoa, Solomon Islands, Tonga, Tuvalu and Vanuatu.
Factsheets can be accessed via the tabs below. It will open in a new tab.